Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability
Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.
Delivery technology may be the missing piece in next-generation obesity therapies.
Lexaria Bioscience is advancing a patented oral delivery platform that improved tolerability in a clinical study by reducing adverse events by up to 50%, targeting a large and growing metabolic treatment market.
Next-generation weight-management drugs face a simple challenge: effectiveness must be matched by tolerability.
Lexaria Bioscience focuses on absorption — the step that determines how a drug behaves in the body.
Its delivery technology reduced adverse events by up to 50% in clinical testing, suggesting improved patient experience without altering the therapeutic compound itself.
Rather than developing a single medication, the company is positioning its platform as a potential enhancement layer for future oral therapies across multiple pharmaceutical categories.
To learn more about Lexaria Bioscience Corp. (NASDAQ: LEXX), watch their video HERE
Published by BTV - The Agency
Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years.
You might also like
CEO Clip - Southern Silver: Can a Growing Silver Resource Support a Major Underground Mine in Mexico?
Southern Silver is advancing the Cerro Las Minitas silver-lead-zinc project in Durango, Mexico, where additional drilling is being incorporated into an updated mineral resource estimate and Preliminary Economic Assessment.
Southern Silver: Is Cerro Las Minitas Emerging as a Major Silver Project?
Southern Silver is advancing its flagship Cerro Las Minitas silver-lead-zinc project in Mexico, which management describes as one of the larger, higher-grade silver-based projects globally.
ASTER BRINGS VERTICAL INTEGRATION TO CLINCH RESOURCES
For the next generation of mining companies, success may depend on more than what comes out of the ground. It may also depend on how much of the value chain a company can control. That’s the thinking behind high-quality metallurgical and specialty coal producer Clinch Resources’ (TSX: CLCH) vertically integrated approach, which brings specialized capabilities like those of its subsidiary Aster Resources — Clinch’s mine-to-market platform — under the same corporate umbrella. By combining mining expertise with the infrastructure, logistics and commercial capabilities needed to move its product to market, Clinch is building a more connected business designed to capture greater value at every stage.